Barjeel for Tumors offers radiopharmaceutical cancer treatment
Burjeel Oncology Institute announces the provision of radiopharmaceutical therapy for patients with certain types of cancer in Abu Dhabi, in collaboration with the Department of Health, aiming to precisely target cancer cells and minimize damage to healthy tissues. The treatment relies on the use of radioactive compounds that target specific molecules or receptors on tumor cells, and is administered based on the type of tumor and the patient's condition after careful evaluation and planning by a multidisciplinary team. The therapy is offered in the Nuclear Medicine Department at Burjeel Medical City, requiring specialized equipment and independent monitoring of the response and side effects. This development adds an alternative option for cancer patients and enhances the efficacy and precision of treatment.
Notice: This Is an AI-Generated Summary
Comments (0)